Baurain, J., Robert, C., Mortier, L., Neyns, B., Grange, F., Lebbe, C., . . . Lehmann, F. F. (2018). Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic. ESMO Open.
Chicago Style CitationBaurain, Jean-François, et al. "Association of Homogeneous Inflamed Gene Signature With a Better Outcome in Patients With Metastatic Melanoma Treated With MAGE-A3 Immunotherapeutic." ESMO Open 2018.
Cita MLABaurain, Jean-François, et al. "Association of Homogeneous Inflamed Gene Signature With a Better Outcome in Patients With Metastatic Melanoma Treated With MAGE-A3 Immunotherapeutic." ESMO Open 2018.
Atenció: Aquestes cites poden no estar 100% correctes.